Monocyte-derived circulating microparticles (CD14(+), CD14(+)/CD11b(+) and CD14(+)/CD142(+)) are related to long-term prognosis for cardiovascular mortality in STEMI patients-MedSci.cn

Monocyte-derived circulating microparticles (CD14(+), CD14(+)/CD11b(+) and CD14(+)/CD142(+)) are related to long-term prognosis for cardiovascular mortality in STEMI patients

Chiva-Blanch, G; Bratseth, V; Ritschel, V; Andersen, GO; Halvorsen, S; Eritsland, J; Arnesen, H; Badimon, L; Seljeflot, I

Chiva-Blanch, G (reprint author), CSIC, ICCC, Cardiovasc Res Ctr, Av St Antoni M Claret 167,Pavello 11, Barcelona 08025, Spain.

Abstract

Background: Circulating microparticles (cMPs) have been proposed as novel biomarkers of cardiovascular disease (CVD). We aimed to investigate the prog......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Monocyte-derived circulating microparticles (CD14(+), CD14(+)/CD11b(+) and CD14(+)/CD142(+)) are related to long-term prognosis for cardiovascular mortality in STEMI patients

科室

工具

服务